Unigestion Holding’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-226,859
| Closed | -$11.6M | – | 159 |
|
2024
Q2 | $11.6M | Buy |
226,859
+163,420
| +258% | +$8.38M | 0.64% | 52 |
|
2024
Q1 | $3.44M | Sell |
63,439
-163,420
| -72% | -$8.86M | 0.17% | 79 |
|
2023
Q4 | $11.6M | Sell |
226,859
-251,230
| -53% | -$12.9M | 0.64% | 52 |
|
2023
Q3 | $27.7M | Sell |
478,089
-25,263
| -5% | -$1.47M | 1.7% | 21 |
|
2023
Q2 | $32.2M | Sell |
503,352
-48,656
| -9% | -$3.11M | 1.86% | 19 |
|
2023
Q1 | $37.6M | Buy |
552,008
+131,310
| +31% | +$8.96M | 2.04% | 14 |
|
2022
Q4 | $30.3M | Buy |
420,698
+38,589
| +10% | +$2.78M | 1.61% | 21 |
|
2022
Q3 | $27.4M | Buy |
382,109
+149,183
| +64% | +$10.7M | 1.59% | 20 |
|
2022
Q2 | $17.9M | Buy |
232,926
+40,432
| +21% | +$3.11M | 1% | 33 |
|
2022
Q1 | $14.1M | Buy |
192,494
+61,208
| +47% | +$4.47M | 0.6% | 45 |
|
2021
Q4 | $8.19M | Sell |
131,286
-103,240
| -44% | -$6.44M | 0.33% | 62 |
|
2021
Q3 | $13.9M | Sell |
234,526
-26,039
| -10% | -$1.54M | 0.56% | 46 |
|
2021
Q2 | $17.3M | Sell |
260,565
-440,577
| -63% | -$29.2M | 0.62% | 48 |
|
2021
Q1 | $44.3M | Sell |
701,142
-206,963
| -23% | -$13.1M | 1.57% | 26 |
|
2020
Q4 | $56.3M | Buy |
908,105
+769
| +0.1% | +$47.7K | 1.93% | 22 |
|
2020
Q3 | $54.7M | Sell |
907,336
-55,168
| -6% | -$3.32M | 1.88% | 24 |
|
2020
Q2 | $56.6M | Buy |
962,504
+909,467
| +1,715% | +$53.4M | 1.91% | 17 |
|
2020
Q1 | $2.95M | Buy |
+53,037
| New | +$2.95M | 0.11% | 108 |
|
2019
Q1 | – | Sell |
-422,027
| Closed | -$21.9M | – | 253 |
|
2018
Q4 | $21.9M | Sell |
422,027
-38,839
| -8% | -$2.02M | 0.55% | 65 |
|
2018
Q3 | $28.6M | Sell |
460,866
-230,132
| -33% | -$14.3M | 0.6% | 62 |
|
2018
Q2 | $38.2M | Buy |
+690,998
| New | +$38.2M | 0.76% | 46 |
|